Driving precision oncology discovery: How IDT powers MRD assessment and multi-cancer detection research
Cancer care is evolving, and precision oncology is leading the way. Learn how minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED) are transforming treatment strategies and how IDT is delivering advanced NGS solutions that are precision-engineered to power the research behind this progress.
